학술논문

Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial
Document Type
Article
Source
In Gynecologic Oncology November 2020 159(2):442-448
Subject
Language
ISSN
0090-8258